Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrakm8 Hldgs Regulatory News (TRAK)

  • This share is currently suspended. It was suspended at a price of 9.25
  • There is currently no data for TRAK

Form 8 (OPD) Trakm8 Holdings Plc

16 May 2025 07:00

RNS Number : 9022I
Trakm8 Holdings PLC
16 May 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Trakm8 Holdings Plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Trakm8 Holdings Plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

15 May 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

-

Nil

 

(2) Cash-settled derivatives:

 

Nil

-

Nil

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

-

Nil

-

 

TOTAL:

Nil

-

Nil

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

(A) Ordinary shares of 1 pence each ("Ordinary Shares") held by directors of Trakm8 Holdings Plc and their close relatives:

 

Name

Number of Ordinary Shares held

% of Ordinary Shares held

John Watkins

7,768,7681

15.54

Timothy Cowley

2,268,1272

4.53

Madeline Cowley

1,994,1163

3.99

Nadeem Raza

600,926

1.20

Keith Evans

381,119

0.76

Mark Watkins

318,310

0.63

Jonathan Edwards

4,418

0.00

 

1This figure includes 1,370,714 Ordinary Shares that are held by Linda Watkins who is a close family member of John Watkins.

2This figure includes 159,091 Ordinary Shares that are held by Anne Cowley who is a close family member of Timothy Cowley.

3This figure includes 256,186 Ordinary Shares held by close family members of Madeline Cowley.

 

(B) Options held over Trakm8 Holdings Plc's Ordinary Shares ("Options") by Trakm8 Holdings Plc directors, their close relatives and persons acting in concert2:

 

Name

Date of grant

Number of Options outstanding

Exercise price (£)

Expiry date

Vesting date

Nadeem Raza

24 July 2020

25,000

0.325

23 July 2030

24 July 20231

06 July 2023

25,000

0.17

04 July 2033

06 July 20261

John Watkins

05 March 2019

425,000

0.335

03 March 2029

04 March 20221

24 July 2020

100,000

0.325

23 July 2030

24 July 20231

Timothy Cowley

05 March 2019

50,000

0.335

03 March 2029

04 March 20221

27 November 2020

100,000

0.325

26 November 2030

27 November 20231

18 November 2021

50,000

0.27

18 November 2031

18 November 2024

Madeline Cowley

05 March 2019

25,000

0.335

03 March 2029

04 March 20221

27 November 2020

100,000

0.325

26 November 2030

27 November 20231

18 November 2021

75,000

0.27

18 November 2031

18 November 2024

Jonathan Edwards

05 March 2019

50,000

0.335

03 March 2029

04 March 20221

24 July 2020

25,000

0.20

23 July 2030

24 July 2023

18 November 2021

300,000

0.27

18 November 2031

18 November 2024

06 July 2023

150,000

0.17

04 July 2033

06 July 20261

Keith Evans

28 May 2019

125,000

0.335

26 May 2029

27 May 20221

27 November 2020

25,000

0.325

26 November 2030

27 November 20231

06 July 2023

75,000

0.17

04 July 2033

06 July 20261

Mark Watkins

05 March 2019

375,000

0.335

03 March 2029

04 March 20221

24 July 2020

100,000

0.325

23 July 2030

24 July 20231

27 November 2020

25,000

0.325

26 November 2030

27 November 20231

12 July 2021

300,000

0.16

11 July 2031

11 July 2024

06 July 2023

150,000

0.17

04 July 2033

06 July 20261

 

1Exercise is subject to a performance target whereby the exercise of the Option is conditional on the Company's mid-market share price being £0.50 or higher at the time of exercise.

2The exercise prices for all Options exceeds the offer price of £0.095 per Trakm8 Holdings Plc's Ordinary Shares.

 

(C) Loan notes convertible into Trakm8 Holdings Plc's Ordinary Shares that are held by Trakm8 Holdings Plc directors, their close relatives and persons acting in concert:

 

Name

Date of grant

Number of Ordinary Shares to be issued on conversion1

Exercise price (£)

Expiry date

Microlise Group Plc2

14 September 2022 (varied on 2 April 2024 and 11 April 2025)

12,345,679

0.081

13 September 2025

Nadeem Raza

2 April 2024

1,234,567

0.081

13 September 2025

John Watkins

14 September 2022 (varied on 2 April 2024 and 11 April 2025)

4,938,271

0.081

13 September 2025

2 April 2024

3,395,061

0.081

13 September 2025

Timothy Cowley

14 September 2022 (varied on 2 April 2024 and 11 April 2025)

740,740

0.081

13 September 2025

Madeline Cowley

14 September 2022 (varied on 2 April 2024 and 11 April 2025)

740,740

0.081

13 September 2025

Jonathan Edwards

2 April 2024

308,641

0.081

13 September 2025

 

1Any accrued interest will be satisfied via a cash payment.

2Nadeem Raza is a non-executive director of Trakm8 and owns 600,926 Trakm8 ordinary shares. Mr Raza is also Chief Executive of Microlise Group Plc ("Microlise") a company which also has its shares admitted to trading on AIM. Mr Raza owns 50.05% of the issued share capital of Microlise.

 

(D) Interests of persons acting in concert with Trakm8 Holdings Plc (in addition to those set out in (A) above) in Trakm8 Holdings Plc's Ordinary Shares:

 

Name

Number of ordinary

shares held

% of voting share capital

Microlise Group Plc1

10,000,000

20.010

 

1Nadeem Raza is a non-executive director of Trakm8 and owns 600,926 Trakm8 ordinary shares. Mr Raza is also Chief Executive of Microlise Group Plc ("Microlise") a company which also has its shares admitted to trading on AIM. Mr Raza owns 50.05% of the issued share capital of Microlise.

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

16 May 2025

Contact name:

Jonathan Edwards, Chief Financial Officer

Telephone number:

+44 330 333 4120

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUVVVRVSUVAAR
Date   Source Headline
9th Jul 202510:42 amRNSScheme of Arrangement becomes Effective
9th Jul 20257:30 amRNSSuspension - Trakm8 Holdings PLC
7th Jul 202512:50 pmRNSCourt Sanction of Scheme & Rule 2.9 Announcement
3rd Jul 20256:00 pmRNSTrakm8 Holdings
19th Jun 20254:33 pmRNSResult of Meeting
28th May 20252:55 pmRNSForm 8.3 - Trakm8 Holdings PLC
21st May 20257:00 amRNSPublication and Posting of Scheme Document
19th May 20256:06 pmRNSForm 8.3 - Trakm8 Holdings PLC
19th May 20254:31 pmRNSForm 8.3 - Trakm8 Holdings
16th May 20257:00 amRNSForm 8 (OPD) Trakm8 Holdings Plc
13th May 20253:51 pmRNSForm 8.3 - Trakm8 Holdings Plc
13th May 20251:42 pmRNSForm 8.3 - Trakm8 Holdings Plc
9th May 20255:24 pmRNSForm 8.3 - Trakm8 Holdings Plc
9th May 202512:44 pmRNSForm 8.3 - Trakm8 Holdings plc
9th May 202512:18 pmRNSForm 8.3 - Trakm8 Holdings PLC
8th May 20256:09 pmRNSForm 8.3 - Trakm8 Holdings
8th May 20253:15 pmRNSForm 8.3 - TRAKM8 HOLDINGS PLC
8th May 20253:06 pmRNSForm 8.3 - Trakm8 Holdings
7th May 20257:00 amRNSRule 2.9 Announcement
2nd May 20251:05 pmGNWForm 8.3 - [TRAKM8 HOLDINGS PLC - Opening Disclosure - 01 05 2025] - (CGAML)
1st May 20253:34 pmRNSRecommended cash offer for Trakm8 Holdings PLC
19th Mar 20257:00 amRNSTrading Update
5th Dec 20247:00 amRNSHalf-year Report
11th Oct 20247:00 amRNSContract Extension
19th Sep 202411:31 amRNSResult of AGM
19th Sep 20247:00 amRNSAGM Statement & Trading Update
23rd Aug 20247:00 amRNSNotice of AGM
29th Jul 20247:00 amRNSFinal Results
25th Jun 20247:00 amRNSContract Award & Contract Extension
3rd Apr 20247:00 amRNSTrading Update, Contract Extension & CLNs Issue
22nd Mar 20247:00 amRNSTrading update
24th Nov 20237:00 amRNSHalf-year Report
15th Nov 20239:37 amRNSDirectorate Change
7th Nov 20239:46 amRNSHolding(s) in Company
21st Sep 202311:13 amRNSResult of Annual General Meeting (AGM)
21st Sep 20237:00 amRNSAGM Statement & Trading Update
25th Aug 20237:00 amRNSNotice of AGM and Capital Markets Day
7th Jul 202311:18 amRNSAward of options
4th Jul 20237:00 amRNSFinal Results
25th Apr 20237:00 amRNSYear End Trading Update
20th Apr 20237:00 amRNSContract Award
30th Mar 20237:00 amRNSIceland Foods Awards Contract Extension
29th Mar 20237:00 amRNSSainsbury’s Awards Optimisation Contract Extension
28th Mar 20237:00 amRNSContract Award
22nd Feb 20237:00 amRNSCapital Markets Day
15th Dec 20228:05 amRNSAward of Options
8th Dec 20227:00 amRNSHalf Year Results
28th Nov 202211:58 amRNSDirector Dealing
22nd Sep 202210:46 amRNSResult of Annual General Meeting (AGM)
22nd Sep 20227:00 amRNSAGM Statement & Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.